CA2902624C — Method for producing sulfonyl chloride compound
Assigned to Takeda Pharmaceutical Co Ltd · Expires 2021-05-18 · 5y expired
What this patent protects
Abstract An object of the present invention is to provide a production method of an inteLmediate used in the production method of a sulfonylpyrrole compound useful as a pharmaceutical product. The present invention relates to a method of producing sulfonylpyrrole compound (VI) by…
USPTO Abstract
Abstract An object of the present invention is to provide a production method of an inteLmediate used in the production method of a sulfonylpyrrole compound useful as a pharmaceutical product. The present invention relates to a method of producing sulfonylpyrrole compound (VI) by reacting a pyridine-3-sulfonic acid compound with phosphorus pentachloride in a solvent of chlorobenzene or trifluoromethylbenzene to give a io pyridine-3-sulfonyl chloride compound, reacting the compound without isolation with compound (III) to give compound (IV), and subjecting the compound (IV) to a reductive amination reaction. R3\7 (111) R2---iNN R4 wherein R2 is a hydrocarbon group etc. and R3 and R4 are each a hydrogen atom etc., SO2 (IV) wherein R1 is an optionally substituted pyridin-3-yl group, and the other symbols are as defined above, S02 (/1) wherein R5 is an alkyl group and the other symbols are as . defined above.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.